Skip to main content
Nectar Lifesciences Limited logo

Nectar Lifesciences Limited — Investor Relations & Filings

Ticker · NECLIFE ISIN · INE023H01027 LEI · 335800RY4LGC64KN9C05 BSE.NS Manufacturing
Open in API
Filings indexed 538 across all filing types
Latest filing 2025-07-23 Regulatory Filings
Country IN India
Listing BSE.NS NECLIFE

About Nectar Lifesciences Limited

https://www.neclife.com/

Nectar Lifesciences Limited is a pharmaceutical organization specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company maintains a significant focus on the cephalosporin segment, producing a wide range of oral and sterile products including Cefixime, Cefuroxime Axetil, and Ceftriaxone. Its operations encompass a fully integrated business model supported by large-scale manufacturing facilities that adhere to international regulatory standards such as USFDA and EUGMP. In addition to its core antibiotic portfolio, the company produces menthol and phytochemicals. Nectar Lifesciences serves a global clientele through contract manufacturing and development services, leveraging its research and development capabilities to provide high-quality therapeutic solutions across various international markets.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings Classification · 95% confidence The document is a detailed communication regarding fines levied by stock exchanges (NSE and BSE) on the company for delayed submission of financial results and other compliance issues under SEBI regulations. It includes references to SEBI Master Circulars, fine amounts, payment details, and board comments on these fines. The document is primarily an announcement and explanation of regulatory penalties and compliance status, not a financial report or earnings release. It does not contain financial statements or substantive financial data but rather regulatory correspondence and board commentary on fines. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-07-23 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a corrigendum to the Notice of an Extraordinary General Meeting (EGM) issued by Nectar Lifesciences Ltd. It updates the explanatory statement related to item no. 3 of the EGM notice, specifically about the mode of rewarding shareholders (special dividends and/or buyback of shares). The document is an announcement amending a previously issued meeting notice, not the notice itself or the meeting materials. It does not contain financial statements or detailed financial data, nor is it a report or transcript. It is a regulatory announcement related to shareholder meeting documentation, specifically a corrigendum to a meeting notice. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a corrigendum to the Notice of EGM (which is a solicitation document), and it updates the explanatory statement for shareholder voting, the most appropriate classification is Proxy Solicitation & Information Statement (PSI). Confidence is high because the document explicitly states it is a corrigendum to the EGM notice and is intended to inform shareholders about changes to the meeting notice.
2025-07-23 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-07-19 English
Board Meeting — Other business matters
Board/Management Information Classification · 95% confidence The document is a notice of a Board Meeting scheduled for July 23, 2025, issued by Nectar Lifesciences Ltd. It informs the stock exchanges about the upcoming meeting where the Board will consider shareholder rewards and related matters. The document references compliance with SEBI Listing Regulations and is a formal announcement of a board meeting date and agenda items. It does not contain financial data, audit information, voting results, or any report itself. It is not a report publication announcement since it is not announcing the release of a report but rather a meeting notice. Therefore, the document fits the category of Board/Management Information (MANG), which covers announcements of changes or meetings of the board of directors or senior management.
2025-07-19 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a formal notice from Nectar Lifesciences Ltd. addressed to stock exchanges regarding the publication of a notice under Section 124(6) of the Companies Act, 2013. It concerns the transfer of unpaid/unclaimed dividends and shares to the Investor Education and Protection Fund (IEPF) Authority as per regulatory requirements. The document includes details about the relevant financial year (FY 2017-18), references to the IEPF Rules, and instructions for shareholders to claim their dividends before transfer. The text is a regulatory announcement informing stakeholders about compliance with statutory provisions and the publication of related newspaper notices. It does not contain financial statements, management discussion, or detailed financial data. It is not a report itself but an official announcement of a regulatory action and publication of notices. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-07-16 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a notice of an Extraordinary General Meeting (EGM) for Nectar Lifesciences Ltd., including details about the publication of the notice in newspapers and information about the meeting date and remote e-voting. It is an announcement related to a shareholder meeting rather than the meeting materials themselves or the voting results. The document does not contain financial statements, management discussion, or detailed report content. Therefore, it fits best under the category of a meeting notice publication, which aligns with the category of Report Publication Announcement (RPA) as it announces the notice of the EGM being published for shareholder information and record.
2025-07-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.